Xiamen Amoytop Biotech Co., Ltd. (SHA: 688278)

Market Cap	31.45B
Revenue (ttm)	2.60B
Net Income (ttm)	740.69M
Shares Out	406.80M
EPS (ttm)	1.82
PE Ratio	42.47
Forward PE	31.25
Dividend	0.41 (0.52%)
Ex-Dividend Date	May 23, 2024

Volume	2,707,495
Open	79.23
Previous Close	79.23
Day's Range	77.50 - 80.36
52-Week Range	41.85 - 86.11
Beta	0.45
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 24, 2024

About Xiamen Amoytop Biotech

Xiamen Amoytop Biotech Co., Ltd. engages in the manufacture, marketing, and sale of recombinant protein drugs in China. It provides solutions for diseases, such as viral hepatitis, malignant tumors, and immunotherapy. The company was founded in 1996 and is based in Xiamen, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1996
• Employees: 1,960
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688278

Financial Performance

In 2023, Xiamen Amoytop Biotech's revenue was 2.10 billion, an increase of 37.55% compared to the previous year's 1.53 billion. Earnings were 555.45 million, an increase of 93.52%.